Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Allergan says FDA approves expanded BOTOX label for spasticity treatment » 18:33
07/09/20
07/09
18:33
07/09/20
18:33
ABBV

AbbVie

$97.93 /

-1.35 (-1.36%)

Allergan, an AbbVie…

Allergan, an AbbVie company, announced that the U.S. Food and Drug Administration approved a supplemental Biologics License Application that supports expanded use of BOTOX for the treatment of spasticity in pediatric patients 2 years of age and older, including those with lower limb spasticity caused by cerebral palsy. This label expansion is based on Allergan and another manufacturer selectively waiving orphan exclusivity marketing rights each company held for the use of their respective neurotoxins in the treatment of pediatric patients with spasticity caused by cerebral palsy. BOTOX was first approved in June 2019 for the treatment of pediatric patients with upper limb spasticity and in October 2019 for the treatment of pediatric patients with lower limb spasticity, excluding spasticity caused by cerebral palsy. BOTOX has not been shown to improve upper extremity functional abilities, or range of motion at a joint affected by a fixed contracture.

ShowHide Related Items >><<
ABBV AbbVie
$97.93 /

-1.35 (-1.36%)

ABBV AbbVie
$97.93 /

-1.35 (-1.36%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
ABBV AbbVie
$97.93 /

-1.35 (-1.36%)

ABBV AbbVie
$97.93 /

-1.35 (-1.36%)

ABBV AbbVie
$97.93 /

-1.35 (-1.36%)

ABBV AbbVie
$97.93 /

-1.35 (-1.36%)

Hot Stocks
Mylan announces FDA approval for Hulio » 06:37
07/09/20
07/09
06:37
07/09/20
06:37
MYL

Mylan

$16.20 /

+0.09 (+0.56%)

, ABBV

AbbVie

$99.28 /

-0.06 (-0.06%)

Mylan (MYL) and Fujifilm…

Mylan (MYL) and Fujifilm Kyowa Kirin announced that the FDA has approved Hulio, a biosimilar to AbbVie's (ABBV) Humira, for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis and plaque psoriasis, in both prefilled syringe and auto-injector presentations. In accordance with its patent license agreement with AbbVie, Mylan will be able to launch Hulio in the U.S. during July 2023.

ShowHide Related Items >><<
MYL Mylan
$16.20 /

+0.09 (+0.56%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

MYL Mylan
$16.20 /

+0.09 (+0.56%)

06/18/20 Raymond James
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'
06/18/20 Wedbush
Patent ruling 'creates a significant issue' for Biogen, says Wedbush
03/25/20 Cantor Fitzgerald
Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
02/06/20 BMO Capital
Biogen price target raised to $317 from $297 at BMO Capital
ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
MYL Mylan
$16.20 /

+0.09 (+0.56%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

MYL Mylan
$16.20 /

+0.09 (+0.56%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

MYL Mylan
$16.20 /

+0.09 (+0.56%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

MYL Mylan
$16.20 /

+0.09 (+0.56%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

Conference/Events
Oxford Global Marketing to hold a virtual event » 04:55
07/09/20
07/09
04:55
07/09/20
04:55
ABBV

AbbVie

$99.28 /

-0.06 (-0.06%)

, AZN

AstraZeneca

$54.19 /

+0.7 (+1.31%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$59.58 /

-0.72 (-1.19%)

, GSK

GlaxoSmithKline

$40.72 /

+0.34 (+0.84%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, JAZZ

Jazz Pharmaceuticals

$107.54 /

-1.18 (-1.09%)

, JNJ

Johnson & Johnson

$143.24 /

+0.43 (+0.30%)

, NVS

Novartis

$88.12 /

+0.345 (+0.39%)

, PFE

Pfizer

$33.76 /

-0.27 (-0.79%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, RTRX

Retrophin

$20.86 /

-0.04 (-0.19%)

, SNY

Sanofi

$51.54 /

+0.14 (+0.27%)

, TAK

Takeda Pharmaceutical

$17.49 /

+0.01 (+0.06%)

, TEVA

Teva

$11.39 /

+0.17 (+1.52%)

Formulation &…

Formulation & Delivery Series Biomanufacturing Virtual Congress will be held on July 8-9. Webcast Link

ShowHide Related Items >><<
TEVA Teva
$11.39 /

+0.17 (+1.52%)

TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RTRX Retrophin
$20.86 /

-0.04 (-0.19%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
IPSEY Ipsen
$0.00 /

+ (+0.00%)

06/08/20 Bryan Garnier
Ipsen upgraded to Buy from Neutral at Bryan Garnier
06/01/20 Barclays
Ipsen price target raised to EUR 72 from EUR 62 at Barclays
06/01/20 BofA
Ipsen upgraded to Buy from Neutral at BofA
05/18/20 JPMorgan
Ipsen upgraded to Neutral on Cabometyx potential at JPMorgan
JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

06/23/20 Barclays
Jazz Pharmaceuticals price target raised to $195 from $183 at Barclays
06/01/20 SVB Leerink
Jazz Pharmaceuticals price target raised to $169 from $160 at SVB Leerink
05/06/20 SVB Leerink
Jazz Pharmaceuticals price target lowered to $160 from $169 at SVB Leerink
05/06/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $132 from $141 at Oppenheimer
JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
NVS Novartis
$88.12 /

+0.345 (+0.39%)

07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$33.76 /

-0.27 (-0.79%)

07/08/20 Piper Sandler
Opko Health price target raised to $6 from $4 at Piper Sandler
07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
RTRX Retrophin
$20.86 /

-0.04 (-0.19%)

06/16/20 BTIG
Retrophin initiated with a Buy at BTIG
02/25/20 Barclays
Retrophin downgraded to Equal Weight from Overweight at Barclays
01/13/20 JMP Securities
JMP says continues to like Retrophin opportunity
08/23/19 BMO Capital
Retrophin price target lowered to $33 from $38 at BMO Capital
SNY Sanofi
$51.54 /

+0.14 (+0.27%)

07/08/20 Piper Sandler
Piper upgrades Kiadis on 'platform validating' Sanofi deal
07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TEVA Teva
$11.39 /

+0.17 (+1.52%)

07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
TEVA Teva
$11.39 /

+0.17 (+1.52%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RTRX Retrophin
$20.86 /

-0.04 (-0.19%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

  • 09
    Jun
TEVA Teva
$11.39 /

+0.17 (+1.52%)

TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

TEVA Teva
$11.39 /

+0.17 (+1.52%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

JAZZ Jazz Pharmaceuticals
$107.54 /

-1.18 (-1.09%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

TEVA Teva
$11.39 /

+0.17 (+1.52%)

TAK Takeda Pharmaceutical
$17.49 /

+0.01 (+0.06%)

SNY Sanofi
$51.54 /

+0.14 (+0.27%)

PFE Pfizer
$33.76 /

-0.27 (-0.79%)

NVS Novartis
$88.12 /

+0.345 (+0.39%)

JNJ Johnson & Johnson
$143.24 /

+0.43 (+0.30%)

GSK GlaxoSmithKline
$40.72 /

+0.34 (+0.84%)

BMY Bristol-Myers
$59.58 /

-0.72 (-1.19%)

AZN AstraZeneca
$54.19 /

+0.7 (+1.31%)

ABBV AbbVie
$99.28 /

-0.06 (-0.06%)

Wednesday
Conference/Events
Oxford Global Marketing to hold a virtual event » 09:24
07/08/20
07/08
09:24
07/08/20
09:24
ABBV

AbbVie

$99.34 /

+0.31 (+0.31%)

, AZN

AstraZeneca

$53.49 /

-0.61 (-1.13%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$60.30 /

+0.09 (+0.15%)

, GSK

GlaxoSmithKline

$40.38 /

-0.625 (-1.52%)

, IPSEY

Ipsen

$0.00 /

+ (+0.00%)

, JAZZ

Jazz Pharmaceuticals

$108.72 /

-2.48 (-2.23%)

, JNJ

Johnson & Johnson

$142.81 /

-0.18 (-0.13%)

, NVS

Novartis

$87.77 /

-0.65 (-0.74%)

, PFE

Pfizer

$34.03 /

-0.48 (-1.39%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, RTRX

Retrophin

$20.90 /

+0.34 (+1.65%)

, SNY

Sanofi

$51.40 /

-0.78 (-1.49%)

, TAK

Takeda Pharmaceutical

$17.48 /

-0.18 (-1.02%)

, TEVA

Teva

$11.22 /

-0.31 (-2.69%)

Formulation &…

Formulation & Delivery Series Biomanufacturing Virtual Congress will be held on July 8-9. Webcast Link

ShowHide Related Items >><<
TEVA Teva
$11.22 /

-0.31 (-2.69%)

TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RTRX Retrophin
$20.90 /

+0.34 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

06/24/20 Oddo BHF
AstraZeneca downgraded to Reduce from Buy at Oddo BHF
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
06/10/20 Cowen
AstraZeneca price target raised to $60 from $55 at Cowen
06/10/20 Guggenheim
Merck's bladder cancer failure boosts strategic value of Padcev, says Guggenheim
BAYRY Bayer
$0.00 /

+ (+0.00%)

06/26/20 JPMorgan
Bayer price target raised to EUR 77 from EUR 75 at JPMorgan
06/26/20 Deutsche Bank
Bayer price target raised to EUR 87 from EUR 85 at Deutsche Bank
06/25/20 Morgan Stanley
Bayer price target raised to EUR 88 from EUR 83 at Morgan Stanley
06/25/20 HSBC
HSBC upgrades Bayer to Buy after settlement on most Monsanto cases in U.S.
BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

06/22/20 Morgan Stanley
Morgan Stanley sees Eliquis patent being upheld, ruling being 'imminent'
06/08/20 Bernstein
Gilead, AstraZeneca merger would make sense on economic basis, says Bernstein
06/02/20 Credit Suisse
Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
06/02/20 Cantor Fitzgerald
Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

06/19/20 Barclays
Glaxo belantamab AdCom a surprise, supports cautious view, says Barclays
06/16/20 Roth Capital
Ideaya Biosciences price target raised to $23 from $12 at Roth Capital
05/14/20 UBS
GlaxoSmithKline price target raised to 1,920 GBp from 1,900 GBp at UBS
IPSEY Ipsen
$0.00 /

+ (+0.00%)

06/08/20 Bryan Garnier
Ipsen upgraded to Buy from Neutral at Bryan Garnier
06/01/20 Barclays
Ipsen price target raised to EUR 72 from EUR 62 at Barclays
06/01/20 BofA
Ipsen upgraded to Buy from Neutral at BofA
05/18/20 JPMorgan
Ipsen upgraded to Neutral on Cabometyx potential at JPMorgan
JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

06/23/20 Barclays
Jazz Pharmaceuticals price target raised to $195 from $183 at Barclays
06/01/20 SVB Leerink
Jazz Pharmaceuticals price target raised to $169 from $160 at SVB Leerink
05/06/20 SVB Leerink
Jazz Pharmaceuticals price target lowered to $160 from $169 at SVB Leerink
05/06/20 Oppenheimer
Jazz Pharmaceuticals price target lowered to $132 from $141 at Oppenheimer
JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

07/06/20 Baird
Cooper Companies downgraded to Neutral, Baird see confluence of issues
07/01/20 JMP Securities
Minerva's seltorexant still 'underappreciated' upside driver, says JMP
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
NVS Novartis
$87.77 /

-0.65 (-0.74%)

07/01/20 Piper Sandler
Amgen appeal rules in favor of patent validity, says Piper Sandler
07/01/20 Jefferies
Amgen win on Enbrel patent removes key overhang, says Jefferies
07/01/20 Goldman Sachs
Global Blood Therapeutics upgraded to Buy from Neutral at Goldman Sachs
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
PFE Pfizer
$34.03 /

-0.48 (-1.39%)

07/08/20 Argus
Pfizer positioned for stronger revenue growth in 2021 and beyond, says Argus
07/07/20 Needham
Vaxcyte initiated with a Buy at Needham
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
07/02/20 BMO Capital
Moderna mRNA platform supported by Pfizer vaccine data, says BMO Capital
RHHBY Roche
$0.00 /

+ (+0.00%)

07/03/20 AlphaValue
Roche upgraded to Add from Reduce at AlphaValue
06/29/20 Piper Sandler
Herceptin/Perjecta approval another win for Halozyme, says Piper
06/23/20 Guggenheim
Immunomedics could be M&A fit for several large-cap drugmakers, says Guggenheim
06/10/20 SunTrust
Arcus Biosciences price target raised to $45 from $22 at SunTrust
RTRX Retrophin
$20.90 /

+0.34 (+1.65%)

06/16/20 BTIG
Retrophin initiated with a Buy at BTIG
02/25/20 Barclays
Retrophin downgraded to Equal Weight from Overweight at Barclays
01/13/20 JMP Securities
JMP says continues to like Retrophin opportunity
08/23/19 BMO Capital
Retrophin price target lowered to $33 from $38 at BMO Capital
SNY Sanofi
$51.40 /

-0.78 (-1.49%)

07/06/20 Citi
BioMarin price target raised to $148 from $105 at Citi
07/01/20 Roth Capital
Applied Genetic may attract Sanofi takeover interest, says Roth Capital
06/26/20 SunTrust
Translate Bio initiated with a Buy at SunTrust
06/24/20 Roth Capital
Translate Bio price target raised to $30 from $25 at Roth Capital
TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

06/18/20 RBC Capital
Neurocrine price target raised to $135 from $116 at RBC Capital
06/17/20 Oppenheimer
Takeda deal expands Neurocrine's pipeline into psychiatry, says Oppenheimer
04/20/20 SVB Leerink
Ascendis Pharma price target raised to $170 from $152 at SVB Leerink
03/25/20 Piper Sandler
Piper Sandler backs Overweight on 'well capitalized' Exelixis
TEVA Teva
$11.22 /

-0.31 (-2.69%)

07/02/20 Wells Fargo
Emergent BioSolutions price target raised to $93 from $85 at Wells Fargo
06/26/20 William Blair
Pfenex partner CHMP opinion 'material de-risking event,' says William Blair
06/17/20 Stifel
Amarin settlement with Apotex an 'incremental positive,' says Stifel
06/08/20 Guggenheim
Emergent BioSolutions price target lowered to $87 from $101 at Guggenheim
TEVA Teva
$11.22 /

-0.31 (-2.69%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RTRX Retrophin
$20.90 /

+0.34 (+1.65%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

  • 09
    Jun
TEVA Teva
$11.22 /

-0.31 (-2.69%)

TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

TEVA Teva
$11.22 /

-0.31 (-2.69%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

JAZZ Jazz Pharmaceuticals
$108.72 /

-2.48 (-2.23%)

IPSEY Ipsen
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

TEVA Teva
$11.22 /

-0.31 (-2.69%)

TAK Takeda Pharmaceutical
$17.48 /

-0.18 (-1.02%)

SNY Sanofi
$51.40 /

-0.78 (-1.49%)

PFE Pfizer
$34.03 /

-0.48 (-1.39%)

NVS Novartis
$87.77 /

-0.65 (-0.74%)

JNJ Johnson & Johnson
$142.81 /

-0.18 (-0.13%)

GSK GlaxoSmithKline
$40.38 /

-0.625 (-1.52%)

BMY Bristol-Myers
$60.30 /

+0.09 (+0.15%)

AZN AstraZeneca
$53.49 /

-0.61 (-1.13%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

Tuesday
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 16:42
07/07/20
07/07
16:42
07/07/20
16:42
NVAX

Novavax

$104.58 /

+25.23 (+31.80%)

, REGN

Regeneron

$639.90 /

+13.25 (+2.11%)

, SHAK

Shake Shack

$49.85 /

-3.53 (-6.61%)

, AMZN

Amazon.com

$3,004.68 /

-53.01 (-1.73%)

, SIRI

Sirius XM

$5.78 /

-0.07 (-1.20%)

, SSP

E.W. Scripps

$8.68 /

+0.28 (+3.33%)

, SPOT

Spotify

$262.11 /

+2.035 (+0.78%)

, IHRT

iHeartMedia

$7.11 /

-0.02 (-0.28%)

, RUN

Sunrun

$26.17 /

+4.825 (+22.60%)

, VSLR

Vivint Solar

$14.68 /

+4.05 (+38.10%)

, HRL

Hormel Foods

$48.15 /

+0.16 (+0.33%)

, PPC

Pilgrim's Pride

$16.41 /

-0.345 (-2.06%)

, SAFM

Sanderson Farms

$113.83 /

+0.56 (+0.49%)

, TSN

Tyson Foods

$58.66 /

-0.765 (-1.29%)

, LVGO

Livongo Health

$93.76 /

+16.19 (+20.87%)

, MXL

MaxLinear

$25.30 /

+3.41 (+15.58%)

, EOLS

Evolus

$3.86 /

-1.47 (-27.58%)

, ABBV

AbbVie

$99.34 /

+0.31 (+0.31%)

, COMM

CommScope

$7.95 /

-0.73 (-8.41%)

The S&P was little…

Open Full Text

ShowHide Related Items >><<
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

EOLS Evolus
$3.86 /

-1.47 (-27.58%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

07/08/20 Ladenburg
Novavax downgraded to Neutral from Buy at Ladenburg
07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
REGN Regeneron
$639.90 /

+13.25 (+2.11%)

07/01/20 Oppenheimer
Regeneron price target raised to $675 from $625 at Oppenheimer
06/24/20 Credit Suisse
Regeneron price target raised to $700 from $605 at Credit Suisse
06/24/20 Morgan Stanley
Novartis' syringe suit not a material threat to Regeneron, says Morgan Stanley
06/18/20 Piper Sandler
AbbVie atopic dermatitis data a postive, says Piper Sandler
SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

06/24/20 JPMorgan
Shake Shack price target raised to $51 from $47 at JPMorgan
05/06/20 Deutsche Bank
Shake Shack price target raised to $57 from $51 at Deutsche Bank
05/05/20 MKM Partners
Shake Shack price target raised to $59 from $50 at MKM Partners
05/05/20 SunTrust
Shake Shack price target raised to $55 from $50 at SunTrust
AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

07/07/20 Baird
Amazon.com price target raised to $3,300 from $2,750 at Baird
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
06/30/20 Mizuho
Amazon.com price target raised to $3,100 from $2,550 at Mizuho
06/29/20 Monness Crespi
Amazon.com price target raised to $3,500 from $2,800 at Monness Crespi
SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/23/20 B. Riley FBR
Sirius XM estimate raises could drive stock 're-rating,' says B. Riley FBR
06/02/20 JPMorgan
Sirius XM named a top pick for June at JPMorgan
05/19/20 Pivotal Research
Liberty SiriusXM price target lowered to $52 from $63 at Pivotal Research
SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
SPOT Spotify
$262.11 /

+2.035 (+0.78%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 JPMorgan
Spotify price target raised to $305 from $185 at JPMorgan
07/06/20 Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
07/06/20 Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
RUN Sunrun
$26.17 /

+4.825 (+22.60%)

07/07/20 JPMorgan
Sunrun price target raised to $30 from $24 at JPMorgan
07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

04/29/20
Fly Intel: Top five analyst downgrades
04/29/20 Piper Sandler
Hormel downgraded to Neutral on foodservice risk at Piper Sandler
04/28/20 Piper Sandler
Hormel Foods downgraded to Neutral from Overweight at Piper Sandler
03/26/20
Fly Intel: Top five analyst upgrades
PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

06/29/20
Fly Intel: Top five analyst downgrades
06/29/20 BMO Capital
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
06/29/20 BMO Capital
Pilgrim's Pride downgraded to Market Perform from Outperform at BMO Capital
06/29/20 Barclays
Pilgrim's Pride downgraded to Equal Weight from Overweight at Barclays
SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

06/04/20 BofA
BofA cuts Pilgrim's Pride, Sanderson Farms targets after price fixing indictment
06/03/20 Stephens
Stephens downgrades Pilgrim's Pride after indictment, suspends targets on peers
05/11/20 Stephens
Sanderson Farms price target raised to $150 from $110 at Stephens
04/03/20 Credit Suisse
Sanderson Farms price target lowered to $135 from $160 at Credit Suisse
TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

06/10/20 Credit Suisse
Tyson Foods price target raised to $75 from $70 at Credit Suisse
06/04/20
Fly Intel: Top five analyst upgrades
06/04/20 Bernstein
Tyson Foods upgraded to Outperform with $83 target at Bernstein
LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

07/07/20 William Blair
William Blair says trends helping MaxLinear likely boosting unit being bought
07/07/20 Roth Capital
MaxLinear price target raised to $25 from $22 at Roth Capital
07/07/20 Needham
MaxLinear price target raised to $33 from $23 at Needham
05/04/20 Craig-Hallum
Craig-Hallum bullish on MaxLinear, initiates with a Buy
EOLS Evolus
$3.86 /

-1.47 (-27.58%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
COMM CommScope
$7.95 /

-0.73 (-8.41%)

07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

EOLS Evolus
$3.86 /

-1.47 (-27.58%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

  • 27
    May
  • 12
    Dec
  • 22
    Nov
  • 07
    Nov
  • 25
    Jul
VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SSP E.W. Scripps
$8.68 /

+0.28 (+3.33%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

SAFM Sanderson Farms
$113.83 /

+0.56 (+0.49%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

PPC Pilgrim's Pride
$16.41 /

-0.345 (-2.06%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

MXL MaxLinear
$25.30 /

+3.41 (+15.58%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

IHRT iHeartMedia
$7.11 /

-0.02 (-0.28%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

VSLR Vivint Solar
$14.68 /

+4.05 (+38.10%)

TSN Tyson Foods
$58.66 /

-0.765 (-1.29%)

SPOT Spotify
$262.11 /

+2.035 (+0.78%)

SIRI Sirius XM
$5.78 /

-0.07 (-1.20%)

SHAK Shake Shack
$49.85 /

-3.53 (-6.61%)

RUN Sunrun
$26.17 /

+4.825 (+22.60%)

REGN Regeneron
$639.90 /

+13.25 (+2.11%)

NVAX Novavax
$104.58 /

+25.23 (+31.80%)

LVGO Livongo Health
$93.76 /

+16.19 (+20.87%)

HRL Hormel Foods
$48.15 /

+0.16 (+0.33%)

EOLS Evolus
$3.86 /

-1.47 (-27.58%)

COMM CommScope
$7.95 /

-0.73 (-8.41%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

ABBV AbbVie
$99.34 /

+0.31 (+0.31%)

AMZN Amazon.com
$3,004.68 /

-53.01 (-1.73%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:31
07/07/20
07/07
12:31
07/07/20
12:31
NVAX

Novavax

$102.25 /

+22.9 (+28.86%)

, SHAK

Shake Shack

$50.69 /

-2.69 (-5.04%)

, AMZN

Amazon.com

$3,036.79 /

-20.9 (-0.68%)

, WMT

Walmart

$123.57 /

+4.68 (+3.94%)

, SIRI

Sirius XM

$5.81 /

-0.04 (-0.68%)

, SSP

E.W. Scripps

$8.56 /

+0.16 (+1.90%)

, SPOT

Spotify

$264.50 /

+4.425 (+1.70%)

, IHRT

iHeartMedia

$6.85 /

-0.28 (-3.93%)

, RUN

Sunrun

$26.88 /

+5.535 (+25.93%)

, VSLR

Vivint Solar

$14.73 /

+4.1 (+38.57%)

, LVGO

Livongo Health

$92.17 /

+14.6 (+18.82%)

, MXL

MaxLinear

$24.84 /

+2.955 (+13.50%)

, EOLS

Evolus

$3.63 /

-1.7 (-31.89%)

, ABBV

AbbVie

$100.36 /

+1.33 (+1.34%)

, COMM

CommScope

$8.14 /

-0.54 (-6.22%)

The S&P is little…

Open Full Text

ShowHide Related Items >><<
WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

EOLS Evolus
$3.63 /

-1.7 (-31.89%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

07/07/20 Cantor Fitzgerald
Novavax price target raised to $148 from $88 at Cantor Fitzgerald
07/02/20 B. Riley FBR
Novavax should be bought on weakness from Pfizer data, says B. Riley FBR
06/29/20 B. Riley FBR
Novavax price target raised to $106 from $74 at B. Riley FBR
06/29/20 H.C. Wainwright
Novavax price target raised to $101 from $50 at H.C. Wainwright
SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

06/24/20 JPMorgan
Shake Shack price target raised to $51 from $47 at JPMorgan
05/06/20 Deutsche Bank
Shake Shack price target raised to $57 from $51 at Deutsche Bank
05/05/20 MKM Partners
Shake Shack price target raised to $59 from $50 at MKM Partners
05/05/20 SunTrust
Shake Shack price target raised to $55 from $50 at SunTrust
AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

07/07/20 Baird
Amazon.com price target raised to $3,300 from $2,750 at Baird
07/07/20 Baird
Wayfair price target raised to $225 from $190 at Baird
06/30/20 Mizuho
Amazon.com price target raised to $3,100 from $2,550 at Mizuho
06/29/20 Monness Crespi
Amazon.com price target raised to $3,500 from $2,800 at Monness Crespi
WMT Walmart
$123.57 /

+4.68 (+3.94%)

06/24/20 B. Riley FBR
Hanesbrands products largely sold out at Walmart and Target, says B. Riley FBR
06/22/20 Guggenheim
Walmart price target raised to $145 from $140 at Guggenheim
06/22/20 UBS
Walmart upgraded to Buy from Neutral at UBS
06/03/20 BTIG
Green Dot price target raised to $48 from $40 at BTIG
SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

07/07/20
Stitcher would help Sirius 'future-proof' business, says B. Riley FBR
06/23/20 B. Riley FBR
Sirius XM estimate raises could drive stock 're-rating,' says B. Riley FBR
06/02/20 JPMorgan
Sirius XM named a top pick for June at JPMorgan
05/19/20 Pivotal Research
Liberty SiriusXM price target lowered to $52 from $63 at Pivotal Research
SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

06/25/20 Benchmark
Benchmark sees material benefits if E.W. Scripps sells Stitcher
03/03/20 Wells Fargo
Disney price target lowered to $155 from $180 at Wells Fargo
12/11/19 Guggenheim
Guggenheim says Nexstar, Gray best positioned for 'record' political cycle
SPOT Spotify
$264.50 /

+4.425 (+1.70%)

07/06/20
Fly Intel: Top five analyst downgrades
07/06/20 JPMorgan
Spotify price target raised to $305 from $185 at JPMorgan
07/06/20 Bernstein
Bernstein doubts Spotify will make money off podcasts, downgrades to sell
07/06/20 Bernstein
Spotify downgraded to Underperform from Market Perform at Bernstein
IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

07/01/20
Fly Intel: Top five analyst downgrades
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
07/01/20 BofA
iHeartMedia downgraded to Neutral from Buy at BofA
04/23/20 Guggenheim
iHeartMedia price target lowered to $10 from $21.50 at Guggenheim
RUN Sunrun
$26.88 /

+5.535 (+25.93%)

07/07/20 JPMorgan
Sunrun price target raised to $30 from $24 at JPMorgan
07/07/20 JMP Securities
Vivint Solar downgraded to Market Perform from Outperform at JMP Securities
07/06/20 JMP Securities
Sunrun price target raised to $31 from $19 at JMP Securities
06/15/20 Credit Suisse
Sunrun price target raised to $29 from $18 at Credit Suisse
VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

06/24/20 Goldman Sachs
Vivint Solar downgraded to Neutral from Buy at Goldman Sachs
06/05/20 JMP Securities
Vivint Solar price target raised to $15 from $10 at JMP Securities
06/02/20 Roth Capital
Roth says loan securitizations reopening a positive for residential solar names
LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

07/07/20 KeyBanc
Livongo Health price target raised to $105 from $85 at KeyBanc
07/07/20 Morgan Stanley
Livongo Health price target raised to $89 from $62 at Morgan Stanley
07/07/20 KeyBanc
Livongo Health experiencing higher member enrollment, retention, says KeyBanc
07/06/20 Stephens
Livongo initiated with Overweight, named Best Idea at Stephens
MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

07/07/20 William Blair
William Blair says trends helping MaxLinear likely boosting unit being bought
07/07/20 Roth Capital
MaxLinear price target raised to $25 from $22 at Roth Capital
07/07/20 Needham
MaxLinear price target raised to $33 from $23 at Needham
05/04/20 Craig-Hallum
Craig-Hallum bullish on MaxLinear, initiates with a Buy
EOLS Evolus
$3.63 /

-1.7 (-31.89%)

07/07/20 SunTrust
Evolus price target lowered to $6 from $12 at SunTrust
07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
COMM CommScope
$8.14 /

-0.54 (-6.22%)

07/07/20 Raymond James
CommScope downgraded to Market Perform at Raymond James on valuation
07/07/20 Raymond James
CommScope downgraded to Market Perform from Outperform at Raymond James
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
06/25/20 Raymond James
CommScope price target lowered to $10 from $12 at Raymond James
WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

EOLS Evolus
$3.63 /

-1.7 (-31.89%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

  • 12
    Dec
  • 22
    Nov
  • 07
    Nov
  • 25
    Jul
WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SSP E.W. Scripps
$8.56 /

+0.16 (+1.90%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

MXL MaxLinear
$24.84 /

+2.955 (+13.50%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

IHRT iHeartMedia
$6.85 /

-0.28 (-3.93%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

WMT Walmart
$123.57 /

+4.68 (+3.94%)

VSLR Vivint Solar
$14.73 /

+4.1 (+38.57%)

SPOT Spotify
$264.50 /

+4.425 (+1.70%)

SIRI Sirius XM
$5.81 /

-0.04 (-0.68%)

SHAK Shake Shack
$50.69 /

-2.69 (-5.04%)

RUN Sunrun
$26.88 /

+5.535 (+25.93%)

NVAX Novavax
$102.25 /

+22.9 (+28.86%)

LVGO Livongo Health
$92.17 /

+14.6 (+18.82%)

EOLS Evolus
$3.63 /

-1.7 (-31.89%)

COMM CommScope
$8.14 /

-0.54 (-6.22%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

ABBV AbbVie
$100.36 /

+1.33 (+1.34%)

AMZN Amazon.com
$3,036.79 /

-20.9 (-0.68%)

Recommendations
Evolus price target lowered to $6 from $12 at SunTrust » 08:28
07/07/20
07/07
08:28
07/07/20
08:28
EOLS

Evolus

$5.33 /

-0.15 (-2.74%)

, ABBV

AbbVie

$99.03 /

+0.16 (+0.16%)

SunTrust analyst Gregg…

SunTrust analyst Gregg Gilbert lowered the firm's price target on Evolus (EOLS) to $6 from $12 and keeps a Buy rating on the shares after an adverse ruling by a judge overseeing an ITC case between Allergan (ABBV) / Medytox and Daewoong / Evolus. Tthe analyst notes that the management remains confident in its case ahead of the final determination date of November 6th, but warns that it is difficult to have a strong data-driven opinion on the likelihood of success. Longer term, Gilbert still believes that Evolus can "carve out a nice slice" of the rapidly-growing botulinum toxin market with Jeuveau, which is its "frictionless alternative" to market-leading Botox.

ShowHide Related Items >><<
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ABBV AbbVie
$99.03 /

+0.16 (+0.16%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

07/07/20 Mizuho
Evolus downgraded to Neutral from Buy at Mizuho
07/07/20 H.C. Wainwright
Evolus price target lowered to $7 from $15 at H.C. Wainwright
06/02/20 Mizuho
Evolus fundamentals unchanged despite ITC delay, says Mizuho
05/26/20 Mizuho
Evolus rally Friday has no clear explanation, says Mizuho
ABBV AbbVie
$99.03 /

+0.16 (+0.16%)

07/06/20 Piper Sandler
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler
06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/25/20 RBC Capital
AbbVie price target raised to $125 from $102 at RBC Capital
EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ABBV AbbVie
$99.03 /

+0.16 (+0.16%)

  • 07
    Nov
ABBV AbbVie
$99.03 /

+0.16 (+0.16%)

ABBV AbbVie
$99.03 /

+0.16 (+0.16%)

EOLS Evolus
$5.33 /

-0.15 (-2.74%)

ABBV AbbVie
$99.03 /

+0.16 (+0.16%)

Monday
Recommendations
Biohaven launch of Nurtec 'continues to impress,' says Piper Sandler » 05:02
07/06/20
07/06
05:02
07/06/20
05:02
BHVN

Biohaven Pharmaceutical

$71.19 /

-1.075 (-1.49%)

, ABBV

AbbVie

$98.87 /

-0.25 (-0.25%)

Per Iqvia, the latest…

Per Iqvia, the latest Nurtec growth rate was 8%, while AbbVie's (ABBV) Ubrelvy underperformed at 4%, Piper Sandler analyst Tyler Van Buren tells investors in a research note. The analyst believes Biohaven Pharmaceutical's (BHVN) Nurtec "continues to impress" since launch. With patient retention remaining above 40%, satisfied patients are refilling their prescriptions, says Van Buren, who keeps an Overweight rating on Biohaven with a $100 price target.

ShowHide Related Items >><<
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

06/25/20 Mizuho
Biohaven selloff yesterday a buying opportunity, says Mizuho
06/24/20 Piper Sandler
Piper Sandler stays Overweight Biohaven after troriluzole efficacy signal in OCD
06/23/20 Cantor Fitzgerald
Biohaven Pharmaceutical price target raised to $109 from $82 at Cantor Fitzgerald
06/19/20 Piper Sandler
Biohaven launch of Nurtec continues to impress, says Piper Sandler
ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

06/29/20 Mizuho
AbbVie price target raised to $110 from $101 at Mizuho
06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/25/20 RBC Capital
AbbVie price target raised to $125 from $102 at RBC Capital
06/24/20 BofA
AbbVie Orilissa guidance for 2025 in more jeopardy after Myovant data, says BofA
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

  • 29
    Jan
BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

BHVN Biohaven Pharmaceutical
$71.19 /

-1.075 (-1.49%)

ABBV AbbVie
$98.87 /

-0.25 (-0.25%)

Over a week ago
Recommendations
AbbVie price target raised to $110 from $101 at Mizuho » 07:38
06/29/20
06/29
07:38
06/29/20
07:38
ABBV

AbbVie

$96.10 /

-0.89 (-0.92%)

Mizuho analyst Vamil…

Mizuho analyst Vamil Divan raised the firm's price target on AbbVie to $110 from $101 and keeps a Buy rating on the shares. The analyst says AbbVie remains his top pick in Biopharmaceuticals after updating estimates for the Allergan deal close.

ShowHide Related Items >><<
ABBV AbbVie
$96.10 /

-0.89 (-0.92%)

ABBV AbbVie
$96.10 /

-0.89 (-0.92%)

06/26/20 Raymond James
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL
06/25/20 RBC Capital
AbbVie price target raised to $125 from $102 at RBC Capital
06/24/20 BofA
AbbVie Orilissa guidance for 2025 in more jeopardy after Myovant data, says BofA
06/23/20
Fly Intel: Top five analyst upgrades
ABBV AbbVie
$96.10 /

-0.89 (-0.92%)

ABBV AbbVie
$96.10 /

-0.89 (-0.92%)

ABBV AbbVie
$96.10 /

-0.89 (-0.92%)

ABBV AbbVie
$96.10 /

-0.89 (-0.92%)

Downgrade
Adverum Biotechnologies downgradedat Raymond James on abicipar CRL » 11:53
06/26/20
06/26
11:53
06/26/20
11:53
ADVM

Adverum Biotechnologies

$21.67 /

-1.59 (-6.84%)

, ABBV

AbbVie

$95.78 /

-1.21 (-1.25%)

Raymond James analyst…

Raymond James analyst Dane Leone downgraded Adverum Biotechnologies (ADVM) to Underperform from Market Perform without a price target after AbbVie (ABBV) and Allergan disclosed the receipt of a complete response letter from the FDA concerning the regulatory submission of abicipar pegol for the treatment of wet age-related macular degeneration. Leone says the CRL underscores the perspective of the FDA regarduing the safety of current standard of care and relates to the ongoing controversy around persistent inflammation for ADVM-022 Cohort 1-3 data. The analyst says he now has direct support for his ADVM-022 inflammation concern from the FDA.

ShowHide Related Items >><<
ADVM Adverum Biotechnologies
$21.67 /

-1.59 (-6.84%)

ABBV AbbVie
$95.78 /

-1.21 (-1.25%)

ADVM Adverum Biotechnologies
$21.67 /

-1.59 (-6.84%)

06/26/20 Raymond James
Adverum Biotechnologies downgraded to Underperform at Raymond James
06/16/20 RBC Capital
Adverum Biotechnologies price target raised to $30 from $24 at RBC Capital
05/29/20 Piper Sandler
Adverum Biotechnologies price target raised to $25 from $20 at Piper Sandler
05/12/20 RBC Capital
Adverum Biotechnologies initiated with an Outperform at RBC Capital
ABBV AbbVie
$95.78 /

-1.21 (-1.25%)

06/25/20 RBC Capital
AbbVie price target raised to $125 from $102 at RBC Capital
06/24/20 BofA
AbbVie Orilissa guidance for 2025 in more jeopardy after Myovant data, says BofA
06/23/20
Fly Intel: Top five analyst upgrades
06/23/20 Atlantic Equities
AbbVie upgraded to Overweight from Neutral at Atlantic Equities
ADVM Adverum Biotechnologies
$21.67 /

-1.59 (-6.84%)

ABBV AbbVie
$95.78 /

-1.21 (-1.25%)

  • 12
    Feb
ABBV AbbVie
$95.78 /

-1.21 (-1.25%)

ADVM Adverum Biotechnologies
$21.67 /

-1.59 (-6.84%)

ABBV AbbVie
$95.78 /

-1.21 (-1.25%)

ABBV AbbVie
$95.78 /

-1.21 (-1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.